Related Experiment Video
Updated: Jan 22, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
A response-adaptive randomization procedure for multi-armed clinical trials with normally distributed outcomes.
S Faye Williamson1,2, Sofía S Villar2
1Department of Mathematics and Statistics, Lancaster University, Lancaster, UK.
We developed a new response-adaptive randomization method for clinical trials. This approach improves patient outcomes and trial efficiency compared to traditional methods, even with missing data.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Medical Research
Background:
- Multi-armed trials are crucial for comparing treatments.
- Traditional randomization may not optimize patient benefit or resource allocation.
- Response-adaptive randomization offers potential improvements.
Purpose of the Study:
- To introduce a novel, non-myopic response-adaptive randomization procedure for multi-armed trials with continuous outcomes.
- To enhance patient benefit and trial efficiency in clinical research.
- To provide a computationally feasible algorithm adaptable for known or unknown variances.
Main Methods:
- The proposed algorithm is derived from the Gittins index for multi-armed bandit problems.
- It modifies a previously introduced method (Villar et al., Biometrics, 2015).
- Simulations were conducted for phase II cancer trials, including online imputation for missing data.
Main Results:
- Response-adaptive allocation with continuous endpoints showed efficiency and patient benefit gains over binary endpoints in multi-armed trials.
- These advantages were maintained despite online imputation of missing data.
- The proposed designs outperformed traditional equal randomization in efficiency and patient benefit.
Conclusions:
- The novel response-adaptive randomization procedure offers significant advantages for multi-armed trials.
- Continuous outcomes and response-adaptive designs enhance both trial efficiency and patient well-being.
- This method provides a valuable tool for optimizing clinical trial strategies, particularly in oncology research.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Cells of the Adaptive Immune Response
Muscles that Move the Arm
The pectoralis major has two origins. Its clavicular head originates on the medial half of the clavicle. In contrast, the sternocostal head originates on the costal cartilages of ribs 1-6, the sternum, and the aponeurosis of the external oblique of the...
Trial and Error and Algorithm

